Jeva, Francis Jade S.

HRN: 22-07-90  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
CEFUROXIME 750MG (VIAL)
10/24/2022
10/31/2022
IVTT
750mg
Q8h
Lamellar Ichthyosis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: